the ambient gas that surrounds the vacuum enclosed apparatus should be ionized. This gas ionization is confirmed by the characteristic orange-red of neon glow discharge that is seen when the Xray source is operated in a low pressure neon environment (Fig. 1b) .
The authors chose silicone because of its strong tendency to charge negatively; a list known as the triboelectric series 8 exists that ranks a material according to its propensity to become charged. To test their device, they added silver to the epoxy surface, and observed the characteristic Xray Kline emissions (around 22-25 keV) of silver. In doing so, Hird et al. prove conclusively that electrons from the discharge process are accelerated to tens of kilo electronvolts of energy and produce Xrays on impact with the epoxy. The capa bility to load epoxy with materials of different atomic number gives the apparatus flexibility -it can both be tuned to a desired Xray line emission energy and increase the efficiency with which Xrays are generated.
What's more, Hird and colleagues 2 find that, by reducing the ambient pressure, the Xray emission can persist for more than a second after the epoxy and silicone have been sepa rated. However, to increase the Xray yield with contactcycle frequency, it is more desir able to achieve short bursts of Xray emission. Although this is at the expense of Xray energy, the emission time can be reduced to less than 10 milliseconds when the device is operated at a higher ambient pressure of 30 millitorr of nitrogen. At such pressure, the authors were able to demonstrate linear scaling of photon number with the frequency of contact cycles. This scaling suggests that the limiting factor to achieving a photon yield of 10 8 per second is finding a linear actuator capable of millimetre displacement and a contactcycle frequency of 0.1-1 kHz. Their 'mark 1' device was based on a solenoidmagnet actuator capable of 20Hz contactcycle frequency. Their 'mark 2' model ( Fig. 1) , which works with a 'piezoelectric' actuator, can achieve a frequency of 300 Hz.
But contactcycle frequency may not be the only way to increase the Xray yield of Hird and colleagues' apparatus. The triboelectric series and literature suggest that material pairs exist for which contact or frictional electrification leads to charge densities of 10 13 electrons per square centimetre 8, 9 . 
Persistence pays off
Developing AIDS vaccines has been a frustrating business. A vaccine that triggers immune responses that effectively control early infection by the simian counterpart of HIV in macaques seems promising. See Letter p.523
IV is a highly mutable virus that has evolved over millennia to escape host control 1 . It is not surprising, there fore, that researchers have faced numerous challenges in inducing effective responses by the T cells and B cells of the immune system against this virus 2 . Over the past decade, con siderable effort has gone into developing AIDS vaccines designed to induce Tcell responses that slow disease progression; such vaccines, however, are unlikely to prevent the explosive burst of viral replication that occurs during primary infection 2 . On page 523 of this issue, Hansen et al. 3 describe an alternative approach. They report that in rhesus macaques, the induction of a distinct type of T cell (the effector memory T cell) may limit the early stages of replication of SIV -a virus related to HIV that infects monkeys.
The immune system can recognize pathogens years after initial exposure using a specialized population of T cells called mem ory T cells. These cells can be divided into two subsets: effector memory T (T EM ) cells and central memory T (T CM ) cells 4 ( Table 1) . T EM cells patrol effector sites such as mucosal tissues -the main port of entry for most infectious pathogens, including HIV -and can rapidly kill the infected cells. Efficient maintenance of T EM cells requires continu ous antigen stimulation. For example, cyto megalovirus (CMV), a herpesvirus that sets up a persisting infection, is well documented as inducing highfrequency T EM cell responses 5 . By contrast, T CM cells are primarily found in secondary lymphoid tissues such as lymph nodes and spleen, and are elicited by non persisting pathogens or vaccines that provide only transient antigenic stimulation 4, 6 . How efficiently T EM and T CM cells can . Indeed, this group previously dem onstrated 8 that RhCMV/SIV -a recombinant rhesus CMV vaccine expressing multiple SIV proteins -could reduce the risk of progressive infection following repeated rectal SIV admin istration, most probably by inducing relatively high levels of CD4 + and CD8 + T EM cells. In their new work 3 , Hansen et al. extend this approach to a larger cohort of animals. In addi tion, they examine the effects of a conventional DNA/recombinant adenovirus vaccine that predominantly induces a T CM cell response. And they give a third group of animals the RhCMV/SIV vaccine first and then boost them with the adenovirus vaccine.
Following repeated rectal challenges of vaccinated and control animals with SIV, 13 of 24 animals that received the RhCMV/SIV vac cine showed a distinctive pattern of transient increase in SIV levels in their blood (viraemia) followed by a rapid decay in the virus levels and then periodic blips of viraemia that became less frequent over the ensuing year. This pattern of transient viraemia(s) stands in stark contrast to the typical course of persistent, highlevel viral replication generally observed after SIV infection of macaques.
The animals that could 'control' SIV infec tion also developed new or increased Tcell responses to the viral protein Vif, which con firmed that a limited 'take' of SIV infection had occurred in these animals. The authors, however, could not detect SIV at postmortem examination in a subset of animals with tran sient SIV infection, despite intensive efforts. Together, these findings suggest that induction of virusspecific T EM cells may control produc tive SIV replication in a presently undefined reservoir of infected cells before the develop ment of progressive, systemic infection.
How can one tell that T EM cells were respon sible for controlling the establishment of progressive SIV infection in these animals? For reasons that are not yet clear, RhCMV vectors do not efficiently induce antibody responses to SIV proteins, including viral envelope proteins. So B cells are unlikely to play a part. More over, the SIVspecific CD4 + and CD8 + T cells in RhCMV/SIVvaccinated animals had a char acteristic T EM phenotype and were enriched in effector sites such as the gut mucosa.
Hansen et al. report that, compared with animals that had progressive SIV infection, those that did not develop such infection had higher peak frequencies of SIVspecific CD8 + T cells after immunization. This suggests that the extent to which mucosal sites are 'seeded' with T EM cells during immunization may be a crucial factor in subsequent control of infec tion. It is essential to determine whether this unusual pattern of viral control can be observed in an independent cohort of animals vaccinated with RhCMV/SIV and to determine which Tcell populations mediate the protective effect. Whether protection occurs when vacci nated macaques are exposed to SIV vaginally or intravenously also remains to be seen. 
